Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants.

Saved in:
Bibliographic Details
Title: Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants.
Authors: Ankrom W; Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA., Xu J; Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA., Vallee MH; Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA., Dockendorf MF; Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA., Armas D; Celerion Inc, Phoenix, Arizona, USA., Boinpally R; Allergan plc, Madison, New Jersey, USA., Min KC; Research Laboratories, Merck & Co, Inc, Kenilworth, New Jersey, USA.
Source: Journal of clinical pharmacology [J Clin Pharmacol] 2020 Sep; Vol. 60 (9), pp. 1157-1165. Date of Electronic Publication: 2020 Apr 16.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1552-4604
DOI:10.1002/jcph.1610